INVO Bioscience, Inc. Business Operations Contracts & Agreements
22 Contracts & Agreements
- Agency Agreements (3 contracts)
- Distribution Agreements (8)
- Management Agreements (2)
- Settlement Agreements (1)
- Supply Agreements (3)
- Termination Agreements (5)
- Management Services Agreement (Filed With SEC on August 11, 2023)
- Placement Agency Agreement by and between the Company and the Placement Agent dated August 4, 2023 (Filed With SEC on August 8, 2023)
- Form of Placement Agency Agreement (Filed With SEC on July 31, 2023)
- Termination Agreement between the Company and Lyfe Medical I, LLC dated May 10, 2023 (Filed With SEC on May 15, 2023)
- Termination Letter between the Company and and Ginekaliks Dooel Skopje dated May 12, 2023 (Filed With SEC on May 15, 2023)
- Placement Agency Agreement by and between the Company and the Placement Agent dated March 23, 2023 (Filed With SEC on March 28, 2023)
- Distribution Agreement with Ming Mei Technology Co. Ltd (Filed With SEC on January 5, 2023)
- Exclusive Distribution Agreement (Filed With SEC on May 16, 2022)
- Termination Notice to Medesole Healthcare and Trading Private Limited dated March 29, 2022 (Filed With SEC on March 31, 2022)
- Termination Notice to Paradigm Opportunities Fund, LP dated March 30, 2022 (Filed With SEC on March 31, 2022)
- INVOcell Supply Agreement (Filed With SEC on December 2, 2021)
- Termination Notice (Filed With SEC on November 8, 2021)
- Management Services Agreement (Filed With SEC on June 30, 2021)
- INVOcell Supply Agreement (Filed With SEC on June 30, 2021)
- Amendment No. 1 to Distribution Agreement (Filed With SEC on March 8, 2021)
- Distribution Agreement (Filed With SEC on December 8, 2020)
- Distribution Agreement (Filed With SEC on November 25, 2020)
- Settlement Agreement and General Release dated November 11, 2019 (Filed With SEC on November 14, 2019)
- Supply Agreement between the INVO Bioscience, Inc and Ferring International Center S.A (Filed With SEC on April 16, 2019)
- EX- 10.04 Customer Distribution Agreement - Canada - MediTech First (Filed With SEC on April 15, 2009)
- EX- 10.05 Customer Distribution Agreement - Turkey - Gonagen (Filed With SEC on April 15, 2009)
- EX- 10.06 Customer Distribution Agreement - Peru- CRHL (Filed With SEC on April 15, 2009)
